A team of researchers led by Professor Yaakov Nahmias, director of the Grass Center for Bioengineering at Hebrew University of Jerusalem and founder of Tissue Dynamic, has presented a new technological approach with the potential to develop new drugs quickly and rapidly and without animal testing.

With the 4th call for funding within the Computational Life Sciences (CompLS) program of the German Federal Ministry of Education and Research (BMBF), the topic "AI methods for infection research" has been defined.

Researchers at the University of Bern and at Inselspital Bern have cultivated so-called prostate organoids and successfully tested their efficacy with various drugs. In this way, it is possible to determine which therapy is most likely to benefit patients before starting treatment.

Scientists at the Berlin Institute of Health (BIH) at Charité - University Hospital Berlin, together with colleagues from Munich and the United Kingdom, have shown that multimorbidity in older people - suffering from several diseases at the same time - often has a common cause.